Renaissance Technologies’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131K | Sell |
16,936
-500
| -3% | -$3.86K | ﹤0.01% | 3257 |
|
|
2025
Q1 | $104K | Sell |
17,436
-49,704
| -74% | -$295K | ﹤0.01% | 3195 |
|
|
2024
Q4 | $894K | Sell |
67,140
-594
| -0.9% | -$7.91K | ﹤0.01% | 2557 |
|
|
2024
Q3 | $551K | Buy |
67,734
+21,670
| +47% | +$176K | ﹤0.01% | 2744 |
|
|
2024
Q2 | $392K | Buy |
46,064
+6,849
| +17% | +$58.2K | ﹤0.01% | 2800 |
|
|
2024
Q1 | $680K | Buy |
39,215
+14,299
| +57% | +$248K | ﹤0.01% | 2721 |
|
|
2023
Q4 | $319K | Sell |
24,916
-8,248
| -25% | -$106K | ﹤0.01% | 2964 |
|
|
2023
Q3 | $1.23M | Sell |
33,164
-51,512
| -61% | -$1.91M | ﹤0.01% | 2162 |
|
|
2023
Q2 | $3.41M | Buy |
84,676
+27,168
| +47% | +$1.09M | ﹤0.01% | 1651 |
|
|
2023
Q1 | $4.17M | Buy |
57,508
+50,908
| +771% | +$3.69M | 0.01% | 1582 |
|
|
2022
Q4 | $541K | Sell |
6,600
-6,844
| -51% | -$561K | ﹤0.01% | 2913 |
|
|
2022
Q3 | $1.27M | Buy |
13,444
+4,436
| +49% | +$419K | ﹤0.01% | 2353 |
|
|
2022
Q2 | $1.75M | Sell |
9,008
-13,784
| -60% | -$2.68M | ﹤0.01% | 2288 |
|
|
2022
Q1 | $5.29M | Buy |
+22,792
| New | +$5.29M | 0.01% | 1552 |
|
|
2021
Q4 | – | Sell |
-11,267
| Closed | -$5.04M | – | 3886 |
|
|
2021
Q3 | $5.04M | Sell |
11,267
-24,681
| -69% | -$11M | 0.01% | 1459 |
|
|
2021
Q2 | $14M | Buy |
35,948
+14,904
| +71% | +$5.79M | 0.02% | 961 |
|
|
2021
Q1 | $7.56M | Buy |
21,044
+20,220
| +2,454% | +$7.26M | 0.01% | 1374 |
|
|
2020
Q4 | $404K | Buy |
+824
| New | +$404K | ﹤0.01% | 2915 |
|
|
2020
Q2 | – | Sell |
-1,024
| Closed | -$218K | – | 3425 |
|
|
2020
Q1 | $218K | Buy |
+1,024
| New | +$218K | ﹤0.01% | 3079 |
|
|
2019
Q3 | – | Sell |
-6,086
| Closed | -$3.06M | – | 3419 |
|
|
2019
Q2 | $3.06M | Buy |
+6,086
| New | +$3.06M | ﹤0.01% | 2108 |
|